183 related articles for article (PubMed ID: 36429098)
1. Comprehensive Analysis of the Prognostic Value and Molecular Function of CRNDE in Glioma at Bulk and Single-Cell Levels.
Song L; Li X; Xu X; Huo X; Zheng Y; Wang X; Li D; Zhang J; Wang K; Wang L; Wu Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429098
[TBL] [Abstract][Full Text] [Related]
2. CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.
Zheng J; Liu X; Wang P; Xue Y; Ma J; Qu C; Liu Y
Mol Ther; 2016 Aug; 24(7):1199-1215. PubMed ID: 27058823
[TBL] [Abstract][Full Text] [Related]
3. A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma.
Chen Y; Hu D; Wang F; Huang C; Xie H; Jin L
Aging (Albany NY); 2023 Nov; 15(21):12296-12313. PubMed ID: 37934582
[TBL] [Abstract][Full Text] [Related]
4. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
[TBL] [Abstract][Full Text] [Related]
5. CRNDE/ETS1/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma.
Hu Y; Luo H; Zhu X; Guo H
Comput Math Methods Med; 2021; 2021():7566365. PubMed ID: 34853603
[TBL] [Abstract][Full Text] [Related]
6. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.
Wang G; Pan J; Zhang L; Wei Y; Wang C
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28940804
[TBL] [Abstract][Full Text] [Related]
8. CRNDE: A Pivotal Oncogenic Long Non-Coding RNA in Cancers.
Hor YZ; Salvamani S; Gunasekaran B; Yian KR
Yale J Biol Med; 2023 Dec; 96(4):511-526. PubMed ID: 38161583
[TBL] [Abstract][Full Text] [Related]
9. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
Wang W; Wu F; Zhao Z; Wang KY; Huang RY; Wang HY; Lan Q; Wang JF; Zhao JZ
CNS Neurosci Ther; 2018 Oct; 24(10):957-966. PubMed ID: 29577647
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.
Zhu Y; Li B; Xu G; Han C; Xing G
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34633056
[TBL] [Abstract][Full Text] [Related]
12. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways.
Jiang H; Wang Y; Ai M; Wang H; Duan Z; Wang H; Zhao L; Yu J; Ding Y; Wang S
Cell Death Dis; 2017 Jun; 8(6):e2862. PubMed ID: 28594403
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.
Ding C; Han F; Xiang H; Xia X; Wang Y; Dou M; Zheng J; Li Y; Xue W; Ding X; Tian P
J Cell Biochem; 2018 Dec; 119(12):10406-10414. PubMed ID: 30129055
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression.
Ding J; Li J; Wang H; Tian Y; Xie M; He X; Ji H; Ma Z; Hui B; Wang K; Ji G
Cell Death Dis; 2017 Aug; 8(8):e2997. PubMed ID: 28796262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]